See also this year's filing and all EDGAR filings for this company.
PDF Report 0001900520_2025_Lomond_Therapeutics_Holdings_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.1519080311448813, 'aggregate_val': 5496524, 'exp_sum': 2554256, 'exp_to_value': {'LiabilitiesCurrent': 2554256, 'LiabilitiesNonCurrent': 0, 'remainder_Liabilities': 0}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001900520, Lomond Therapeutics Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 29,251,789 |
| 1 | AssetsNonCurrent | 0 |
| 2 | remainder_Assets | 0 |
| 3 | LiabilitiesCurrent | 2,554,256 |
| 4 | LiabilitiesNonCurrent | 0 |
| 5 | remainder_Liabilities | 2,942,268 |
| 6 | GeneralAndAdministrativeExpense | 1,941,963 |
| 7 | ProfessionalFees | 0 |
| 8 | remainder_Expenses | 15,282,916 |
| 9 | remainder_Revenues | 0 |
| 10 | remainder_NetIncome | 137,426 |
| 11 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 29,251,789 |
| 1 | Liabilities | 5,496,524 |
| 2 | Expenses | 17,224,879 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 23,755,265 |
| 5 | NetIncome | -17,087,453 |
| 6 | ComprehensiveNetIncome | -17,087,453 |
| 7 | BaseVar | 26,055,309 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 5.85 |
| 9 | EconomicCapitalRatio | 8.24 |
Edgar->Model Mapping
Feature Distribution
